$YSG

Yatsen posts 2025 Form 20-F, offers free hard copies to holders

Yatsen (NYSE: YSG) filed its 2025 annual report on Form 20-F with the U.S. SEC on April 29, 2026, covering the fiscal year ended December 31, 2025. The report is available on the company's investor relations website and the SEC website. Shareholders and ADS holders can request free hard copies by written request to the company's Investor Relations Department.

Original reporting
Published Apr 29, 2026, 9:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Apr 30, 2026, 7:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Yatsen posts 2025 Form 20-F, offers free hard copies to holders — source image
Decision brief

The 30-second read

$YSGNeutralLow
01

Why it matters

The filing demonstrates regulatory compliance and shareholder engagement but is unlikely to influence stock price significantly in the short term.

02

Market read

Low immediate market impact; relevant mainly for long-term investors and analysts monitoring corporate governance and transparency.

03

What to watch

Potential for minor positive sentiment boost among long-term investors valuing transparency; however, this is unlikely to influence short-term trading.

Timing: Low; the news pertains to annual report filing and shareholder communications, not immediate market catalysts.

Background

Yatsen, a Chinese cosmetics company listed on NYSE, filed its annual report for 2025, complying with SEC requirements.

Company-level read

Ticker impact

$YSGNeutralMedium confidence
Context

Primary focus due to recent SEC filing and shareholder communications.

Expected impact

Minimal immediate price movement; potential slight positive bias over the long term.

Evidence & confidence

The filing is standard regulatory compliance; the offer of free copies is a shareholder service with limited market impact.

Market effects

Limited; the company's sector may experience minor positive sentiment due to increased transparency.

Negligible; the news is company-specific and pertains to US SEC filings.

Minimal; no broader market implications.

Counterpoint

Some investors may interpret the filing as a routine compliance measure with no significant impact, thus avoiding any trading adjustments.

Key entities

  • Yatsen

    A Chinese cosmetics company listed on NYSE.

Related articles

$YSGMedAI 8/10

Yatsen (YSG) Q2 2026 Earnings Call Transcript

Yatsen (YSG) reported Q2 2026 net revenue of RMB 1.14B, up 5.1% YoY, driven by skincare growth offsetting color cosmetics decline. Gross margin fell to 73.9% from 78.3% due to inventory provisions. Operating loss widened to RMB 131.9M. Q3 revenue guidance is RMB 898.6M-998.4M, a 0-10% YoY decrease. Management highlighted strategic shifts and industry challenges.

$YSGMed

Yatsen Holding Q2 Loss Widens, Shares Down

Yatsen Holding Ltd. (YSG) reported a wider Q2 2026 loss, with net loss increasing to $13.39M from $17.67M YoY, due to higher expenses. Revenue rose to $168.34M from $108.6M. Shares fell 4.51% premarket. The company forecasts Q3 revenue between $898.6M and $998.4M, a potential YoY decrease of 0% to 10%.

$YSGMed

Yatsen Holding Ltd (YSG): Financial results for Q2 2026

Yatsen Holding Ltd (YSG) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Yatsen Announces Second Quarter 2026 Financial Results Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on September 2, 2026 GUANGZHOU, China, September 2, 2026 – Yatsen Holding Limited (“Yatsen” or the “Company”) (NYSE: YSG), a leading China-based beauty gr

$YSGHigh

Yatsen Announces Second Quarter 2026 Financial Results

Yatsen (YSG) reported Q2 2026 revenue growth of 5.1% to $168.3M, driven by a 40.4% increase in skincare sales. Gross margin fell to 73.9% from 78.3% due to higher inventory provisions. Net loss widened to $13.4M from $1.9M. The company is refocusing on high-growth skincare brands.